These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23462228)
41. Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats. Bakali E; Mbaki Y; Lambert DG; Elliott RA; Mason R; Tincello DG Int Urogynecol J; 2016 Sep; 27(9):1393-400. PubMed ID: 26942594 [TBL] [Abstract][Full Text] [Related]
42. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice. Zhang RS; He Z; Jin WD; Wang R Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221 [TBL] [Abstract][Full Text] [Related]
43. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902 [TBL] [Abstract][Full Text] [Related]
44. Effects of the synthetic cannabinoid 5F-AMB on anxiety and recognition memory in mice. Ito S; Deyama S; Domoto M; Zhang T; Sasase H; Fukao A; Esaki H; Hinoi E; Kaneko S; Kaneda K Psychopharmacology (Berl); 2019 Jul; 236(7):2235-2242. PubMed ID: 30868181 [TBL] [Abstract][Full Text] [Related]
45. Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal. Kupferschmidt DA; Newman AE; Boonstra R; Erb S Neuroscience; 2012 Mar; 204():125-33. PubMed ID: 21784132 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756 [TBL] [Abstract][Full Text] [Related]
47. Sacred Maya incense, copal (Protium copal - Burseraceae), has antianxiety effects in animal models. Merali Z; Cayer C; Kent P; Liu R; Cal V; Harris CS; Arnason JT J Ethnopharmacol; 2018 Apr; 216():63-70. PubMed ID: 29414121 [TBL] [Abstract][Full Text] [Related]
48. Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT McLaughlin PJ; Jagielo-Miller JE; Plyler ES; Schutte KK; Vemuri VK; Makriyannis A Psychopharmacology (Berl); 2017 Mar; 234(6):1029-1043. PubMed ID: 28144708 [TBL] [Abstract][Full Text] [Related]
49. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain. Deng L; Cornett BL; Mackie K; Hohmann AG Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556 [TBL] [Abstract][Full Text] [Related]
50. Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors. Hayase T BMC Neurosci; 2013 Feb; 14():20. PubMed ID: 23394117 [TBL] [Abstract][Full Text] [Related]
51. Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice. Gholizadeh S; Shafaroodi H; Ghasemi M; Bahremand A; Sharifzadeh M; Dehpour AR Neuropharmacology; 2007 Nov; 53(6):763-70. PubMed ID: 17870135 [TBL] [Abstract][Full Text] [Related]
52. Sex, THC, and hormones: Effects on density and sensitivity of CB Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834 [TBL] [Abstract][Full Text] [Related]
53. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584 [TBL] [Abstract][Full Text] [Related]
54. Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice. Chen RZ; Huang RR; Shen CP; MacNeil DJ; Fong TM Brain Res; 2004 Mar; 999(2):227-30. PubMed ID: 14759503 [TBL] [Abstract][Full Text] [Related]
56. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Balerio GN; Aso E; Maldonado R Psychopharmacology (Berl); 2006 Mar; 184(3-4):504-13. PubMed ID: 16416159 [TBL] [Abstract][Full Text] [Related]
57. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073 [TBL] [Abstract][Full Text] [Related]
58. Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice. DeSanty KP; Dar MS Pharmacol Biochem Behav; 2001; 69(1-2):251-9. PubMed ID: 11420093 [TBL] [Abstract][Full Text] [Related]
59. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats. Calik MW; Carley DW Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522 [TBL] [Abstract][Full Text] [Related]